Japan Roussel

Japan Roussel was the Japanese operating subsidiary of the French pharmaceutical company Roussel Uclaf. The company was primarily involved in the marketing and distribution of specialty pharmaceuticals in Japan, with a significant emphasis on hormonal treatments, steroids, and anti-infectives. Through a sequence of industry consolidations starting in the late 1990s, the company was absorbed into Hoechst Marion Roussel, then Aventis, and finally Sanofi. It played a key role in introducing French pharmaceutical innovations to the Japanese market during the late 20th century. The company's legacy continues through Sanofi's current presence in the Japanese healthcare sector.